Health CanadaType III
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation pro...
Published: February 18, 2025Recall ID: 76972Category: generalCountry: Canada
Reason for Recall / Hazard
Product quality
Product Description & Identification
Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada.
Affected Products
CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE
Additional Source Details
| Field | Value |
|---|---|
| N I D | 76972 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/cisatracurium-besylate-injection-usp-multidose-level-degradation-product-benzaldehyde |
| Issue | Product quality |
| Title | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots. |
| Product | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-02-18 |
| Organization | Drugs and health products |
| Recall class | Type III |
| What you should do | Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.Contact the recalling firm if you have any questions about the recall.Report any health product related side effects to Health Canada.Report any other health product safety complaints to Health Canada. |